Gland Pharma Limited Return on Equity (ROE) for the year ending March 31, 2025: 7.63%

Gland Pharma Limited Return on Equity (ROE) is 7.63% for the year ending March 31, 2025, a -13.79% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Gland Pharma Limited Return on Equity (ROE) for the year ending March 31, 2024 was 8.85%, a -9.77% change year over year.
  • Gland Pharma Limited Return on Equity (ROE) for the year ending March 31, 2023 was 9.81%, a -42.03% change year over year.
  • Gland Pharma Limited Return on Equity (ROE) for the year ending March 31, 2022 was 16.93%, a 0.24% change year over year.
  • Gland Pharma Limited Return on Equity (ROE) for the year ending March 31, 2021 was 16.89%, a -20.32% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share